Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769821 · ClinicalTrials.gov registry record
The Impact of Lymphedema on Breast Cancer Survivors
A clinical trial of Breast Cancer and Lymphedema, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT00769821: Completed study of Breast Cancer and Lymphedema, sponsored by University of California, San Francisco.
NCT00769821 is a study of Breast Cancer and Lymphedema that has completed, run by University of California, San Francisco. The registered enrollment target is 145 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00769821, a study of Breast Cancer and Lymphedema, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer survivors.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE assessment of therapy complications
- PROCEDURE bioimpedance spectroscopy
Study Locations (1)
California
- University of California, San Francisco School of Nursing - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-02 |
What the finished NCT00769821 record still lists
NCT00769821 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT00769821 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00769821 about?
NCT00769821 is a clinical study titled "The Impact of Lymphedema on Breast Cancer Survivors". RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer...
What is the current status of trial NCT00769821?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2007-02. Estimated completion is 2009-02.
What conditions does trial NCT00769821 study?
This clinical trial studies the following conditions: Breast Cancer, Lymphedema, Cancer Survivor, Perioperative/Postoperative Complications.
What interventions are being tested in trial NCT00769821?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), assessment of therapy complications (PROCEDURE), bioimpedance spectroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00769821?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00769821 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00769821's enrollment target sits among peer trials
145 456th of 1224 higher than 766 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia